Although activating mutations in ras genes are the most common genetic
abnormality in human hematologic malignancies, the role of ras mutati
ons as an initiating event in leukemogenesis remains unclear, To asses
s the consequences of ectopic expression of an activated ras gene in n
ormal hematopoietic cells in vivo, lethally irradiated mice were recon
stituted with bone marrow cells infected with a mutant ras-containing
retrovirus [murine stem cell virus (MSCV)-v-H-ras] based on the MSCV r
etroviral vector which efficiently transduces functional genes into he
matopoietic stem/progenitor cells, Despite a marked myeloid leukocytos
is detectable in the peripheral blood within 4 weeks of engraftment, n
one of 22 primary or secondary transplant recipients studied for longe
r periods of time presented with myeloid neoplasms, Instead, 18 of the
MSCV-v-H-ras mice developed pre-T-celI thymic lymphomas and/or pre-B-
cell lymphoblastic leukemia/lymphomas between 7 and 12 weeks post-tran
splantation. The pre-B and pre-T lymphoid tumors that arose in one ani
mal were shown to harbor a; common MSCV-v-H-ras provirus, indicating t
hat the target cell for transformation was a bipotential lymphoid prec
ursor. To more precisely examine the effects of activated ras expressi
on on the behavior of hematopoietic progenitors, infected bone marrow
cells were assayed in methylcellulose cultures under conditions favora
ble for growth of multilineage myeloid colonies or were passaged as bu
lk suspension cultures in the presence of various hematopoietic growth
factors, including interleukin (IL)-3, IL-4, IL-6 and IL-7. MSCV-dire
cted expression of v-H-ras selectively promoted the formation of large
dense colonies comprised of monocyte-macrophages in methylcellulose c
ultures. When transferred to liquid cultures, the vast majority of the
cells underwent terminal macrophage differentiation, By comparison, t
umorigenic B-lymphoid and mixed lymphoid/myeloid cell lines were routi
nely established from the bulk suspension cultures, with cell lines of
predominantly myeloid phenotype emerging only in IL-6-supplemented cu
ltures/ These results, considered together with previous findings, sug
gest that activating ras mutations could be an initiating genetic alte
ration in human acute lymphoblastic leukemia but are more Likely to be
a postinitiation change in human acute myeloid leukemia.